Friday, July 10, 2020

Drug regulator okays psoriasis injection for limited use in treating COVID-19 patients

Considering the unmet medical needs to treat COVID-19, Drugs
Controller General of India Dr V G Somani approved monoclonal antibody
injection Itolizumab for restricted emergency use for the treatment of
'cytokine' release syndrome in moderate to severe acute respiratory
distress syndrome patients due to COVID-19.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-regulator-okays-psoriasis-injection-for-limited-use-in-treating-covid-19-patients/articleshow/76904178.cms
Posted by at

1 comment:

  1. Maya AaliyahJuly 12, 2020 at 4:19 AM

    Good information. Thanks for sharing. If you want to know more about stock market related topics then visit
    Simple Moving Average
    Scalp trading
    Commodity trading

    ReplyDelete

Subscribe to: Post Comments (Atom)